Ionis Pharmaceuticals (IONS) Long-Term Investments (2010 - 2012)
Ionis Pharmaceuticals' quarterly Long-Term Investments came in at -$5.6 million in Q3 2012, down 76.88% year-on-year from -$24.1 million in Q4 2011, and little changed quarter-over-quarter from -$5.6 million in Q2 2012.
Ionis Pharmaceuticals has reported Long-Term Investments for 3 years, with the latest figure at -$5.6 million in Q3 2012.
- For the quarter ending Q3 2012, Long-Term Investments fell 76.88% year-over-year to -$5.6 million; the trailing twelve-month figure through Sep 2012 stood at -$5.6 million (down 76.88% YoY), and the FY2011 full-year result was -$4.4 million, down 408.51% from the prior year.
- Long-Term Investments for Q3 2012 stood at -$5.6 million, roughly flat from -$5.6 million in the prior quarter.
- The five-year high for Long-Term Investments was -$870000.0 in Q4 2010, with the low at -$5.6 million in Q2 2012.
- Average Long-Term Investments over 3 years is -$3.9 million, with a median of -$4.2 million recorded in 2010.
- Peak annual rise in Long-Term Investments reached 37.1% in 2011, while the deepest fall reached 408.51% in 2011.
- Tracing IONS's Long-Term Investments over 3 years: stood at -$870000.0 in 2010, then sank by 408.51% to -$4.4 million in 2011, then retreated by 25.75% to -$5.6 million in 2012.
- The last three Long-Term Investments figures came in at -$5.6 million (Q3 2012), -$5.6 million (Q2 2012), and -$5.4 million (Q1 2012), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 505,194.89 |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 5.75 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 9.79 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 22.17 Mn |
| 10 | Ionis Pharmaceuticals | 12.61 Bn | 10.69 Bn | 243.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | -5.56 Mn |
| Jun 30, 2012 | -5.56 Mn |
| Mar 31, 2012 | -5.40 Mn |
| Dec 31, 2011 | -4.42 Mn |
| Sep 30, 2011 | -3.15 Mn |
| Jun 30, 2011 | -2.76 Mn |
| Mar 31, 2011 | -1.73 Mn |
| Dec 31, 2010 | -870,000.00 |
| Sep 30, 2010 | -5.00 Mn |
| Jun 30, 2010 | -4.07 Mn |